Search

Search Constraints

You searched for: Author/Creator Shalaby, Sarah

Search Results

1. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis. Issue 1 (January 2019)

2. Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals. (10th September 2019)

3. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH). (8th June 2021)

5. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals. Issue 9 (September 2017)

6. Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation – a multicenter cohort study. (26th February 2021)

7. Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Issue 3 (19th March 2021)

9. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC. Issue 12 (16th August 2021)

10. Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis". (3rd October 2022)